Davis Polk advised the underwriters in the offering. Hydrofarm Holdings Group, Inc. executed its $310.6 million follow-on public offering of 5,526,861 shares of common stock, which includes 720,894...
Hydrofarm Holdings Group’s $310.6 Million Follow-on Offering
Central Garden & Pet’s $400 Million Senior Notes Offering
Simpson Thacher represented the initial purchasers in the offering. Central Garden & Pet Company (“Central”) executed the offering of $400 million aggregate principal amount of 4.125%...
FedEx’s $1.75 Billion Notes Offering
Simpson Thacher represented the underwriters in the offering. FedEx Corporation (“FedEx”) executed its offering of $1 billion aggregate principal amount of 2.4% Notes due 2031 and...
ATP Tower’s $375 Million Notes Offering
Simpson Thacher represented the initial purchasers for the offering. ATP Tower Holdings, LLC (“ATP”) and certain of its subsidiaries acted as co-issuers of an aggregate principal amount...
Shinhan Bank’s $6 Billion GMTN Program Update and $500 Million Senior Unsecured Notes Offering
Simpson Thacher represented dealers and joint managers in the transaction. Shinhan Bank completed its update of the US$6 billion Global Medium Term Note program. In addition Shinhan...
NeuroPace’s $102 Million Initial Public Offering
Davis Polk advised the representatives of the several underwriters in the offering. NeuroPace, Inc. executed its initial public offering of 6,900,000 shares of common stock at...
UiPath’s $1.54 Billion Initial Public Offering
Davis Polk advised the representatives of the several underwriters on the deal while Cooley LLP represented UiPath. UiPath, Inc. executed its $1.54 billion initial public offering of...
JPMorgan Chase’s $13 Billion Bond Offering
Simpson Thacher & Bartlett LLP represented JPMorgan Chase, while Cravath, Swaine & Moore LLP represented the underwriters in the offering. JPMorgan Chase & Co. closed its public...
Recursion Pharmaceuticals’ $500 Million Initial Public Offering
Davis Polk advised the representatives of the several underwriters in the offering. Recursion Pharmaceuticals, Inc. executed its $500 million initial public offering of 27,878,787 shares of Class...
Akoya Biosciences’ $151.3 Million Initial Public Offering
Davis Polk advised the representatives of the several underwriters in the offering. Akoya Biosciences, Inc. executed its $151.3 million initial public offering of 7,567,000 shares of common...
Berkshire Hathaway’s ¥160 Billion Yen-Denominated Bond Offering
Simpson Thacher represented the underwriters in the offering. Berkshire Hathaway Inc. (“Berkshire”) executed the registered public offering of ¥160 billion aggregate principal amount of debt securities, consisting...
Bloomin’ Brands’ $300 Million High-Yield Senior Notes Offering
Simpson Thacher represented the initial purchasers in the offering. Bloomin’ Brands, Inc. (“Bloomin’”) and its wholly-owned subsidiary OSI Restaurant Partners, LLC executed a debut high-yield 144A/Regulation S...